2018

Abbasi O, Hirschmann J, Storzer L, Özkurt TE, Elben S, Vesper J, Wojtecki L, Schmitz G, Schnitzler A, Butz M. Unilateral deep brain stimulation suppresses alpha and beta oscillations in sensorimotor cortices. Neuroimage 2018; 174: 201-207.

Adriani M, Nytrova P, Mbogning C, Hässler S, Medek K, Jensen PEH, Creeke P, Warnke C, Ingenhoven K, Hemmer B, Sievers C, Lindberg Gasser RL, Fissolo N, Deisenhammer F, Bocskei Z, Mikol V, Fogdell-Hahn A, Kubala Havrdova E, Broët P, Dönnes P, Mauri C, Jury EC; ABIRISK Consortium. Monocyte NOTCH2 expression predicts IFN-β immunogenicity in multiple sclerosis patients. JCI Insight 2018; 3: e99274.

Aktas O. Ein Paradigmenwechsel und die Zukunft. In: Berger T, Linnebank M, Wiendl H (eds.) Betaferon® 2013, 25 Jahre Multiple Sklerose Forschung. Springer 2018, in press.

Aktas O, Wattjes MP, Stangel M, Hartung HP. Diagnose der Multiplen Sklerose: Revision der McDonald-Kriterien 2017. Nervenarzt 2018, in press.

Albrecht P, Petzold LA, Lagreze W, Brand BA. OCT retinal layer nomenculature. Author Response. Neurology 2018, in press.

Albrecht P, Jansen A, Moll M, Ringelstein M, Rosenthal D, Bigalke H, Hartung HP, Hefter H. High prevalence of neutralizing antibodies in long-term botulinum neurotoxin treated patients with spasticity or dystonia. Neurology 2018, in press.

Albrecht P, Bjørnå IK, Brassat D, Farrell R, Feys P, Hobart J, Hupperts R, Linnebank M, Magdič J, Oreja-Guevara C, Pozzilli C, Salgado AV, Ziemssen T. Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience. Report of an expert meeting. Therapeutic Advances in Neurological Disorders 2018; 11: 1-8.

Arendt G. Die HIV-assoziierte Demenz (HAD) in der Ära moderner antiretroviraler Kombinationstherapien (cART). Brandt, Diener, Gerloff (eds.) Der Neurologe & Psychiater 2018, in press.

Arendt G, Nolting T. Neuropsychiatric side effects of efavirenz therapy. Journal of Neurobehavioral HIV Medicine 2018, in press.

Arendt G, Maschke M. HIV-Infektion und AIDS: neurologische Manifestationen. In: Brandt, Diener, Gerloff (eds.) Therapie und Verlauf neurologischer Erkrankungen. Kohlhammer Verlag, 6. Aufl., 2018, in press.

Azim K, Akkermann R, Cantone M, Jadasz J, Vera J, Küry P. Transcriptional profiling of ligand expression in cell specific populations of the adult mouse forebrain that regulates neurogenesis. Frontiers in Neuroscience 2018; 12: 220.

Baumgarten TJ, Neugebauer J, Oeltzschner G, Füllenbach ND, Kircheis G, Häussinger D, Lange J, Wittsack HJ, Butz M, Schnitzler A. Connecting occipital alpha band peak frequency, visual temporal resolution, and occipital GABA levels in healthy participants and hepatic encephalopathy patients. Neuroimage Clinical 2018; 20: 347-356.

Bendfeldt K, Taschler B, Gaetano L, Madoerin P, Kuster P, Mueller-Lenke N, Amann M, Vrenken H, Wottschel V, Barkhof F, Borgwardt S, Klöppel S, Wicklein EM, Kappos L, Edan G, Freedman MS, Montalbán X, Hartung HP, Pohl C, Sandbrink R, Sprenger T, Radue EW, Wuerfel J, Nichols TE. MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry. Brain Imaging & Behavior 2018, in press

Berndt C, Engelke AD, Bräutigam L, Lepka, K. Glutaredoxins in the brain. In: Flohé L, (ed.) Glutathione Systems in Health and Disease, CRC Press, 2018, in press.

Bismarck von O, Dankowski T, Ambrosius B, Hessler N, Antony G,, Ziegler A, Hoshi MM, Aly L, Luessi F, Groppa S, Klotz L, Meuth SG, Tackenberg B, Stoppe M, Then Bergh F, Tumani H, Kümpfel T, Stangel M, Heesen C, Wildemann B, Paul F, Bayas A, Warnke C, et al.; On behalf of the German Competence Network Multiple Sclerosis (KKNMS). Treatment choices and neuropsychological symptoms of a large cohort of early MS. Neurology, Neuroimmunology & Neuroinflammation 2018; 5: e446.

Blasberg F, Wojtecki L, Elben S, Slotty PJ, Vesper J, Schnitzler A, Groiss SJ. Comparison of Awake vs. Asleep Surgery for Subthalamic Deep Brain Stimulation in Parkinson's Disease. Neuromodulation 2018; 21: 541-547.

Bovis F, De Stefano N, Steinerman JR, Knappertz V, Sormani MP. Validating the use of brain volume cutoffs to identify clinically relevant atrophy in RRMS. Multiple Sclerosis 2018, in press.

Broussalis E, Grinzinger S, Kunz AB, Killer-Oberpfalzer M, Haschke-Becher E, Hartung HP, Kraus J. Late age onset of amyotrophic lateral sclerosis is often not considered in elderly people. Acta Neurologica Scandinavica 2018; 137: 329-334.

Buck D, Andlauer TF, Igl W, Wicklein EM, Mühlau M, Weber F, Köchert K, Pohl C, Arnason B, Comi G, Cook S, Filippi M, Hartung HP, Jeffery D, Kappos L, Barkhof F, Edan G, Freedman MS, Montalbán X, Müller-Myhsok B, Hemmer B; The BEYOND and BENEFIT Study Groups. Effect of HLA-DRB1 alleles and genetic variants on the evelopment of neutralizing antibodies to interferon beta in he BEYOND and BENEFIT trials. Multiple Sclerosis Journal 2018, in press.

Cadavid D, Mellion M, Hupperts R, Edwards KR, Calabresi PA, Drulović J, Giovannoni G, Hartung HP, Rudick R, Mi S, Chai Y, Li J, Zhang Y, Xu L, Zhu B, Green SM, Chang I, Deykin A, Sheikh S; on behalf of the SYNERGY study investigators. Efficacy and safety of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial. Lancet Neurology 2018, in press.

Cadavid D, Balcer L, Galetta S, Aktas O, Ziemssen T, Vanopdenbosch LJ, Leocani L, Freedman MS, Plant GT, Preiningerova JL, Ziemssen F, Massacesi L, Chai Y, Xu L; RENEW Study Investigators. Predictors of response to opicinumab in acute optic neuritis. Annals of Clinical and Translational Neurology 2018; 5: 1154-1162.

Cohen JA, Comi G, Arnold DL, Bar-Or A, Selmaj KW, Steinman L, Havrdová EK, Cree BA, Montalbán X, Hartung HP, Huang V, Frohna P, Skolnick BE, Kappos L; RADIANCE Trial Investigators. Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized phase II study. Multiple Sclerosis 2018, in press.

Cornblath DR, Hartung HP, Katzberg HD, Merkies ISJ, van Doorn PA. A randomized, multicentre phase III study of three different doses of intravenous immunoglobulin 10% in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ProCID trial): Study design and protocol. Journal of the Peripheral Nervous System 2018; 23: 108-114.

D'hooghe M, Van Gassen G, Kos D, Bouquiaux O, Cambron M, Decoo D, Lysandropoulos A, Van Wijmeersch B, Willekens B, Penner IK, Nagels G. Improving fatigue in multiple sclerosis by smartphone-supported energy management: The MS TeleCoach feasibility study. Multiple Sclerosis and Related Disorders 2018; 22: 90-96.

Dietrich M, Helling N, Hilla A, Heskamp A, Issberner A, Hildebrandt T, Kohne Z, Küry P, Berndt C, Aktas O, Fischer D, Hartung HP, Albrecht P. Early alpha-lipoic acid therapy protects from degeneration of the inner retinal layers and vision loss in an experimental autoimmune encephalomyelitis-optic neuritis model. Journal of Neuroinflammation 2018; 15: 71.

Dietrich M, Hecker C, Hilla A, Cruz-Herranz A, Hartung HP, Fischer D, Green A, Albrecht P. Using optical coherence tomography and optokinetic response as structural and functional visual system readouts in mice and rats. Journal of Visualized Experiments 2018, in press.

Doets AY, Verboon C, van den Berg B, Harbo T, Cornblath DR, Willison HJ, Islam Z, Attarian S, Barroso FA, Bateman K, Benedetti L, van den Bergh P, Casasnovas C, Cavaletti G, Chavada G, Claeys KG, Dardiotis E, Davidson A, van Doorn PA, Feasby TE, Galassi G, Gorson KC, Hartung HP, Hsieh ST, Hughes RA, Illa I, Islam B, Kusunoki S, Kuwabara S, Lehmann HC, Miller JA, Mohammad QD, Monges S, Orazio EN, Pardo J, Pereon Y, Rinaldi S, Querol L, Reddel SW, Reisin RC, Shahrizaila N, Sindrup SH, Waqar W, Jacobs BC; the IGOS consortium..Regional variation of Guillain-Barré syndrome. Brain 2018; 141: 2866-2877.

Elben S, Trenado C, Vesper J, Schnitzler A, Wojtecki L. Human subthalamic oscillatory dynamics following somatosensory stimulation. Clinical Neurophysiology 2018; 129: 79-88.

Ferrea S, Saleh A, Wojtecki L, Schnitzler A, Südmeyer M. Diabetic hemichorea-hemiballism – Case report of a patient with endurig striatal lesion. Basal Ganglia 2018, in press.

Ferrea S, Groiss SJ, Elben S, Hartmann CJ, Dunnett SB, Rosser A, Saft C, Schnitzler A, Vesper J, Wojtecki L; Surgical Approaches Working Group of the European Huntington’s Disease Network (EHDN). Pallidal deep brain stimulation in juvenile Huntington's disease: local field potential oscillations and clinical data. Journal of Neurology 2018; 265; 1573-1579.

Fernández O, Delvecchio M, Edan G, Fredrikson S, Giovannoni G, Hartung HP, Havrdova E, Kappos L, Pozzilli C, Soelberg Soerensen P, Tackenberg B, Vermersch P, Comi G. Survey of diagnostic and treatment practices for multiple sclerosis in Europe, part 2: progressive MS, paediatric MS, pregnancy and general management. European Journal of Neurology 2018; 5: 739-746.

Filser M, Schreiber H, Pöttgen J, Ullrich S, Lang M, Penner IK. The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS): results from the German validation study. Journal of Neurology 2018; 265: 2587-2593.

Fischer D, Klaus A, Ray DE. Toxikologie des Nervensystems. In: Marquardt H, Schäfer S, Barth H (eds.) Toxikologie. 3. Aufl., Wissenschaftliche Verlagsgesellschaft Stuttgart, 2018, in press.

Förster M, Küry P, Aktas O, Warnke C, Havla J, Hohlfeld R, Hartung HP, Kremer D. Managing risks with immune therapies in multiple sclerosis. BioDrugs 2018, in press.

Garcia Bonitto JR, Carra A, Cárcamo C, Correa P, Fragoso Y, Guerra Posada C, Hartung HP, Macias Islas M, Montañés P, Novarro N, Orozco G, Rodriguez V, Steinberg J, Vizcarra D. Latin-American forum of experts in multiple sclerosis updated management recommendations for multiple sclerosis in Latin America. Journal of the Neurological Sciences 2018, in press.

Gliem M, Krammes K, Liaw L, van Rooijen N, Hartung HP, Jander S. Macrophage-derived osteopontin induces reactive astrocyte polarization and promotes re-establishment of the blood brain barrier after ischemic stroke. Glia 2018, in press.

Goettle P, Manousi A, Kremer D, Reiche L, Hartung HP, Küry P. Teriflunomide promotes oligodendroglial differentiation and myelination. Journal of Neuroinflammation 2018; 15: 76.

Goettle P, Förster M, Gruchot J, Kremer D, Hartung HP, Perron H, Küry P. Rescuing the negative impact of human endogenous retrovirus envelope protein on 1 oligodendroglial differentiation and myelination. Glia 2018, in press.

Goodin P, Lamp G, Vidyasagar R, McArdle D, Seitz RJ, Carey LM. Altered functional connectivity differs in stroke survivors with impaired touch sensation following left and right hemisphere lesions. Neuroimage Clinical 2018; 18: 342-355.

Graf J, Jansen L, Ingwersen J, Ringelstein M, Harmel J, Rybak J, Kolbe R, Rhöse L, Gemerzki L, Lee JI, Klistorner A, Guthoff R, Hartung HP, Aktas O, Albrecht A. Multifocal visual evoked potentials in chronic inflammatory demyelinating polyneuropathy. Annals of Clinical and Translational Neurology 2018; 5: 952-961.

Graf J, Ringelstein M, Lepka K, Schaller J, Quack H, Hartung HP, Aktas O, Albrecht P. Acute sarcoidosis in a multiple sclerosis patient after alemtuzumab treatment. Multiple Sclerosis Journal 2018, in press.

Groiss SJ, Butz M, Baumgarten T, Füllenbach N-D, Häussinger D, Schnitzler A. Stage dependent alteration of cortical excitability in patients with hepatic encephalopathy. Clinical Neurophysiology 2018, in press.

Gross J, Kujala J, Salmelin R, Schnitzler A. Non-invasive functional tomographic connectivity analysis with magnetoencephalography. In: Kringelbach M, Hansen P, Salmelin R (eds.) Magnetoencephalography. An introduction to methods. Oxford University Press, Oxford, 2018 in press.

Gruber D, Südmeyer M, Deuschl G, Falk D, Krauss JK, Mueller J, Müller JU, Poewe W, Schneider GH, Schrader C, Vesper J, Volkmann J, Winter C, Kupsch A, Schnitzler A; DBS study group for dystonia. Neurostimulation in tardive dystonia/dyskinesia: A delayed start, sham stimulation-controlled randomized trial. Brain Stimulation 2018; 11: 1368-1377.

Hari R, Baillet S, Barnes G, Burgess R, Forss N, Gross J, Hämäläinen M, Jensen O, Kakigi R, Mauguière F, Nakasato N, Puce A, Romani GL, Schnitzler A, Taulu S. IFCN-endorsed practical guidelines for clinical magnetoencephalography (MEG). Clinical Neurophysiology 2018; 129: 1720-1747.

Hari R, Baillet S, Barnes G, Forss N, Gross J, Hämäläinen M, Jensen O, Kakigi R, Mauguière F, Nakasato N, Puce A, Romani GL, Schnitzler A, Taulu S. Reply to "Clinical practice guidelines or clinical research guidelines?" Clinical Neurophysiology 2018; 129: 2056-2057.

Hartung HP, Matthews V, Ross AP, Pitschnau-Michel D, Thalheim C, Ward-Abel N; on behalf of the Multiple Sclerosis-Nurse Empowering Education (MS-NEED) Study Group. Disparities in nursing of multiple sclerosis patients – results of a European nurse survey. Multiple Sclerosis Journal 2018, in press.

Hartung HP, Meuth SG, Ruck T, Aktas O. Cladribin-Tabletten: orale Immuntherapie der schubförmigen Multiplen Sklerose mit kurzen jährlichen Behandlungsphasen. Nervenarzt 2018; 89: 895-907.

Hassan SS, Trenado C, Elben S, Schnitzler A, Groiss SJ. Alteration of cortical excitability and its modulation by Miglustat in Niemann-Pick disease type C. Journal of Clinical Neuroscience 2018; 47: 214-217.

Hassan SS, Baumgarten T, Ali AW, Füllenbach N-D, Jördens, M, Butz M, Häussinger D, Schnitzler A, Groiss SJ. Cerebellar inhibition in hepatic encephalopathy – a transcranial magnetic stimulation study. Clinical Neurophysiology 2018, in press.

Haupts MR, Spill-Askeridis P, Humpert M, Seidel D, Hartung HP. Acute exacerbations after decades of non-active chronic multiple sclerosis. Multiple Sclerosis 2018; 24: 1265-1266.

Havrdová E, Arnold DL, Bar-Or A, Comi G, Hartung HP, Kappos L, Lublin F, Selmaj K, Traboulsee A, Belachew S, Bennett I, Buffels R, Garren H, Han J, Julian L, Napieralski J, Hauser SL, Giovannoni G. No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a. Multiple Sclerosis Journal Experimental, Translational and Clinical 2018; 4: 2055217318760642.

Heckel M, Kieseier BC, Schaper J, Mayatepek E, Rosenbaum T. Mitoxantrone as rescue therapy in two children with worsening multiple sclerosis. Journal of Pediatric Neurology 2018, in press.

Hefter H, Tezayak O, Rosenthal D. Long-term outcome of neurological Wilson´s disease. Parkinsonism & Related Disorders 2018; 49: 48-53.

Hensel L, Hoffstaedter F, Caspers J, Michely J, Mathys C, Heller J, Eickhoff CR, Reetz K, Südmeyer M, Fink GR, Schnitzler A, Grefkes C, Eickhoff SB.Functional Connectivity Changes of Key Regions for Motor Initiation in Parkinson's Disease. Cerebral Cortex 2018, in press.

Hilla A, Fischer D. Studying the Role of Microglia in Neurodegeneration and Axonal Regeneration in the Visual System. Bio-Protocol 2018, in press.

Hughes R, Dalakas M, Merkies I, Latov N, Léger JM, Nobile-Orazio E, Sobue G, Genge A, Cornblath D, Merschhemke M, Ervin CM, Agoropoulou C, Hartung HP. Randomised controlled trial of oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial). Lancet Neurology 2018; 17: 689-698.

Husstedt IW, Maschke M, Eggers C, Neuen-Jacob E, Arendt G. Zika-Virus-Infektion und das Nervensystem. Nervenarzt 2018; 89: 136-143.

Ingold I, Berndt C, Schmitt S, Doll S, Poschmann G, Buday K, Roveri A, Peng X, et al. Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis. Cell 2018; 172: 1-14.

Ingwersen J, de Santi L, Wingerath B, Graf J, Koop B, Schneider R, Hecker C, Schröter F, Bayer M, Engelke AD, Dietrich M, Albrecht P, Hartung HP, Annunziata P, Aktas O, Prozorovski T. Nimodipine confers clinical improvement in two models of experimental autoimmune encephalomyelitis. Journal of Neurochemistry 2018, in press.

Jadasz JJ, Tepe L, Beyer F, Samper Agrelo I, Akkermann R, Spitzhorn LS, Silva ME, Oreffo R, Hartung HP, Prigione A, Rivera F, Adjaye J, Küry P. Human mesenchymal factors induce rat hippocampal- and human neural stem cell dependent oligodendrogenesis. Glia 2018; 66:145-160.

Jarius S, Paul F, Aktas O, Asgari N, Dale RC, de Seze J, Franciotta D, Fujihara K, Jacob A, Kim HJ, Kleiter I, Kümpfel T, Levy M, Palace J, Ruprecht K, Saiz A, Trebst C, Weinshenker BG, Wildemann B. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. Journal of Neuroinflammation 2018; 15: 134.

Jensen PEH, Warnke C, Ingenhoven K, Piccoli L, Gasis M, Hermanrud C, Fernandez-Rodriguez BM, Ryner M, Kramer D, Link J, Ramanujam R, Auer M, Buck D, Grummel V, Bertotti E, Fissolo N, Oliver-Martos B, Nytrova P, Khalil M, Guger M, Rathmaier S, Sievers-Stober C, Lindberg RLP, Hässler S, Bachelet D, Aktas O, Donnellan N, Lawton A, Hemmer B, Havrdova EK, Kieseier B, Hartung HP, Comabella M, Montalban X, Derfuss T, Sellebjerg F, Dönnes P, Pallardy M, Spindeldreher S, Broët P, Deisenhammer F, Fogdell-Hahn A, Sorensen PS; ABIRISK Consortium. Detection and kinetics of persistent neutralizing anti-interferon-beta antibodies in patients with multiple sclerosis. Results from the ABIRISK prospective cohort study. Journal of Neuroimmunology 2018; 326: 19-27.

Kapoor R, Ho PR, Campbell N, Chang I, Deykin A, Forrestal F, Lucas N, Yu B, Arnold DL, Freedman MS, Goldman MD, Hartung HP, Havrdová E, Jeffery D, Miller A, Sellebjerg F, Cadavid D, Mikol D, Steiner D. Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomized, double-blind, placebo-controlled trial with an open-label extension. Lancet Neurology 2018; 5: 405-415.

Kieseier BC, Hartung HP. Fortschritte im Erkennen und Behandeln von Polyneuropathien. Deutsches Ärzteblatt 2018; 115: 81-82.

Kieseier BC, Wiendl H. Schädigungsmechanismen bei Multipler Sklerose. In: Zettl U, Mix E (eds.) Multiple Sklerose. Springer, Berlin, 2018, in press.

Kieseier BC. Entzündungsmediatoren als biologische Marker – Zytokine, Chemokine, Adhäsionsmoleküle und Metalloproteasen. In: Berger T (ed.) Biologische Marker für Diagnostik, Prognose und Therapie bei MS. Uni-Med Verlag, Bremen, 2018, in press.

Kieseier BC, Wiendl H. Therapie der Multiplen Sklerose – Aktuelles therapeutisches Vorgehen und Perspektiven. Uni-med Verlag, Bremen, 2018, in press.

Kieseier BC, Wiendl H. Corroborating the orale therapeutic pathway in multiple sclerosis – new evidence for teriflunomide (Editorial) Lancet Neurology 2018, in press.

Kieseier BC,  Mathey E, Sommer C, Hartung HP. Immune-mediated neuropathies. Nature Reviews Disease Primers 2018; 4: 31.

Kim SH, Mealy MA, Levy M, Schmidt F, Ruprecht K, Paul F, Ringelstein M, Aktas O, Hartung HP, Asgari N, Tsz-Ching JL, Siritho S, Prayoonwiwat N, Shin HJ, Hyun JW, Han M, Leite MI, Palace J, Kim HJ. Racial differences in neuromyelitis optica spectrum disorder. Neurology 2018, in press.

Kleiser R, Nickel N, Seitz RJ, Trenkler J, Wurm G. Brain Tumors: Clinical Applications of Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging. In: Tumors of the Central Nervous System. Springer, Heidelberg, Chapter 20, 2018, in press.

Kleiter I, Gahlen A, Borisow N, Fischer K, Wernecke KD, Hellwig K, Pache F, Ruprecht K, Havla J, Kümpfel T, Aktas O, Hartung HP, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Stellmann JP, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Krumbholz M, Zeltner L, Ziemann U, Linker R, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Zettl UK, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C; NEMOS (Neuromyelitis Optica Study Group). Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions. Neurology, Neuroimmunology & Neuroinflammation 2018; 5: e504.

Klistorner A, Chai Y, Leocani L, Albrecht P, Aktas O, Butzkueven H, Ziemssen T, Ziemssen F, Frederiksen J, Xu L, Cadavid D; RENEW MF-VEP Investigators. Assessment of Opicinumab in Acute Optic Neuritis Using Multifocal Visual Evoked Potential. CNS Drugs 2018, in press.

Kraayvanger L, Berlit P, Albrecht P, Hartung HP, Kraemer M. Cerebrospinal fluid findings in reversible cerebral vasoconstriction syndrome: a way to differentiate from cerebral vasculitis? Clinical and Experimental Immunology 2018; 193: 341-345.

Kraemer M, Karakaya R, Matsushige T, Graf J, Albrecht P, Hartung HP, Berlit P, Laumer R, Diesner F. Efficacy of STA-MCA bypass surgery in moyamoya angiopathy: long-term follow-up of the Caucasian Krupp Hospital cohort with 81 procedures. Journal of Neurology 2018; 265: 2425-2433.

Kraemer M, Sassen J, Karakaya R, Schwitalla JC, Graf J, Albrecht P, Hartung HP, Diehl RR, Berlit P, Laumer R, Diesner F. Moyamoya angiopathy: early postoperative course within 3 months after STA-MCA-bypass surgery in Europe-a retrospective analysis of 64 procedures. Journal of Neurology 2018; 265: 2370-2378.

Kremer D, Küry P, Hartung HP. ECTRIMS/ACTRIMS 2017: Closing in on neurorepair in progressive multiple sclerosis. Multiple Sclerosis 2018; 24: 696-700.

Kremer D, Akkermann R, Küry P, Dutta R. Current advancements in promoting remyelination in multiple sclerosis. Multiple Sclerosis 2018, in press.

Küry P, Nath A, Créange A, Dolei A, Marche PN, Gold J, Giovannoni G, Hartung HP, Perron H. Human Endogenous Retroviruses in Neurological Diseases. Trends Molecular Medicine 2018; 4: 379-394.

Küry P, Kremer D, Göttle P. Drug repurposing for neuroregeneration in multiple sclerosis. Neural Regeneration Research 2018; 13: 1366-1367.

Lange J, Kapala K, Krause H, Baumgarten TJ, Schnitzler A. Rapid temporal recalibration to visuo-tactile stimuli. Experimental Brain Research 2018; 236: 347-354.

Lehmann HC, Compston A, Hartung HP. 150th anniversary of clinical description of multiple sclerosis: Leopold Ordenstein’s legacy. Neurology 2018; 90: 1011-1016.

Leussink VI, Hartung HP, Reifenberger J. A case of alopecia universalis associated with alemtuzumab treatment in multiple sclerosis. Neurology, Neuroimmunology & Neuroinflammation 2018; 5: e454.

Leussink VI, Montalban X, Hartung HP. Restoring axonal function with 4-Aminopyridine: clinical efficacy in multiple sclerosis and beyond. CNS Drugs 2018; 32: 637-651.

Levin E, Leibinger M, Gobrecht P, Hilla A, Andreadaki A ,Fischer D. Muscle LIM Protein is expressed in the injured adult CNS and promotes Axon Regeneration. Cell Reports 2018, in press.

Lhommée E, Wojtecki L, Czernecki V, Witt K, Maier F, Tonder L, Timmermann L, Hälbig TD, Pineau F, Durif F, Witjas T, Pinsker M, Mehdorn M, Sixel-Döring F, Kupsch A, Krüger R, Elben S, Chabardès S, Thobois S, Brefel-Courbon C, Ory-Magne F, Regis JM, Maltête D, Sauvaget A, Rau J, Schnitzler A, Schüpbach M, Schade-Brittinger C, Deuschl G, Houeto JL, Krack P; EARLYSTIM study group. Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial. Lancet Neurology 2018; 17: 223-231.

Liebmann M, Hucke S, Koch K, Eschborn M, Ghelman J, Chasan AI, Glander S, Schädlich M, Kuhlencord M, Daber NM, Eveslage M, Beyer M, Dietrich M, Albrecht P, Stoll M, Busch KB, Wiendl H, Roth J, Kuhlmann T, Klotz L. Nur77 serves as a molecular brake of the metabolic switch during T cell activation to restrict autoimmunity. Proceedings of the National Academy of Sciences of the United States of America 2018; 115: e8017-e8026.

Lindenberg R, Seitz RJ. Impact of white matter damage after stroke. In: Neuroimaging / Book 1. Intech Publisher, 2018, in press.

Löbermann M, Handorn B, Winkelmann A, Reisinger EC, Hartung HP, Zettl UK. Multiple Skerlose und Hepatitis-B-Impfung. Nervenarzt. 2018; 89: 1172-1178.

Manoucheri N, Zhang Y, Salter A, Hartung HP, Hemmer B, Segal BM , Cutter G, Olaf Stϋve O. Clinical trials in multiple sclerosis:  Prospective future trial designs. Therapeutic Advances in Neurological Disorders 2018, in press.

Mausberg AK, Szepanowski F, Odoardi F, Flügel A, Kleinschnitz C, Stettner M, Kieseier BC. Trapped in the epineurium: early entry into the endoneurium is restricted to neuritogenic T cells in experimental autoimmune neuritis. Journal of Neuroinflammation 2018; 15: 217.

Mengel D, Fraune L, Sommer N, Stettner M, Reese JP, Dams J, Glynn RJ, Balzer-Geldsetzer M, Dodel R, Tackenberg B. Costs of illness in chronic inflammatory demyelinating polyneuropathy in Germany. Muscle & Nerve 2018; 58: 681-687.

Meuth SG, Ruck T, Aktas O, Hartung HP. Cladribin-Tabletten. Orale Immuntherapie der schubförmigen Multiplen Sklerose mit kurzen, jährlichen Behandlungsphasen. Nervenarzt 2018; 89: 895-907.

Miller DH, Lublin FD, Sormani MP, Kappos L, Yaldizli Ö, Freedman MS, Cree BAC, Weiner HL, Lubetzki C, Hartung HP, Montalban X, Uitdehaag BMJ, MacManus DG, Yousry TA, Gandini Wheeler-Kingshott CAM, Li B, Putzki N, Merschhemke M, Häring DA, Wolinsky JS. Brain atrophy and disability worsening in primary progressive multiple sclerosis: insights from the INFORMS study. Annals of Clinical and Translational Neurology 2018; 5: 346-356.

Moldovan AS, Hartmann CJ, Trenado C, Meumertzheim N, Slotty PJ, Vesper J, Schnitzler A, Groiss SJ. Less is more - Pulse width dependent therapeutic window in deep brain stimulation for essential tremor. Brain Stimulation 2018; 11: 1132-1139.

Montalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D, Clanet M, Comi G, Derfuss T, Fazekas F, Hartung HP, Havrdova E, Hemmer B, Kappos L, Liblau R, Lubetzki C, Marcus E,. Miller DH, Olsson T, Pilling S, Selmaj K, Siva A, Sorensen PS, Sormani MP, Thalheim C, Wiendl H, Zipp F. ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis. Multiple Sclerosis 2018; 24: 96-120.

Montalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D, Clanet M, Comi G, Derfuss T, Fazekas F, Hartung HP, Havrdova E, Hemmer B, Kappos L, Liblau R, Lubetzki C, Marcus E,. Miller DH, Olsson T, Pilling S, Selmaj K, Siva A, Sorensen PS, Sormani MP, Thalheim C, Wiendl H, Zipp F. ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis. European Journal of Neurology 2018; 25: 215-237.

Mueller SH, Färber A, Prüss H, Melzer N, Golombeck KS, Kümpfel T, Thaler F, Elisak M, Lewerenz J, Kaufmann M, Sühs KW, Ringelstein M, Kellinghaus C, Bien CG, Kraft A, Zettl UK, Ehrlich S, Handreka R, Rostásy K, Then Bergh F, Faiss JH, Lieb W, Franke A, Kuhlenbäumer G, Wandinger KP, Leypoldt F; German Network for Research on Autoimmune Encephalitis (GENERATE). Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitis. Annals of Neurology 2018; 83: 863-869.

Muthuraman M, Schnitzler A, Groppa S. Pathophysiologie des Tremors. Nervenarzt 2018; 89: 408-415.

Nessler S, Hemmer B. Multiple Sklerose und andere demyelinisierende Erkrankungen. In: Klockgether T, Dodel R (eds.) Kurzlehrbuch Neurologie 2018, in press.

Neuhaus M, Bagutti S, Yaldizli Ö, Zwahlen D, Schaub S, Frey B, Fischer-Barnicol B, Burgunder JM, Martory MD, Pöttgen J, Annoni JM, Penner IK. Characterization of social cognition impairment in multiple sclerosis. European Journal of Neurology 2018; 25: 90-96.

Oeltzschner G, Zöllner HJ, Jonuscheit M, Lanzman RS, Schnitzler A, Wittsack HJ. J-difference-edited MRS measures of γ-aminobutyric acid before and after acute caffeine administration. Magnetic Resonance in Medicine 2018, in press.

Oertel FC, Havla J, Roca-Fernández A, Lizak N, Zimmermann H, Motamedi S, Borisow N, White OB, Bellmann-Strobl J, Albrecht P, Ruprecht K, Jarius S, Palace J, Leite MI, Kuempfel T, Paul F, Brandt AU. Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study. Journal of Neurology, Neurosurgery & Psychiatry 2018, in press.

Penner IK. Kognitive Störungen bei Multipler Sklerose: Wirklich weiche Symptome? Info Neurologie & Psychiatrie 2018, in press.

Pöttgen J, Moss-Morris R, Wendebourg JM, Feddersen L, Lau S, Köpke S, Meyer B, Friede T, Penner IK, Heesen C, Gold SM. Randomised controlled trial of a self-guided online fatigue intervention in multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry 2018; 89: 970-976.

Rivera FJ, Kraus J, Steffenhagen C, Küry P, Weidner N, Aigner L. Remyelination in multiple sclerosis: The therapeutic potential of neural and mesenchymal stem/progenitor cells. Current Signal Transduction Therapy 2018, in press.

Ruan J, Bludau S, Palomero-Gallagher N, Caspers S, Mohlberg H, Eickhoff SB, Seitz RJ, Amunts K. Cytoarchitecture, probability maps, and functions of the human supplementary and pre-supplementary motor areas. Brain Structure & Function 2018, in press.

Schaik van IN, Bril V , Geloven van N, Hartung HP, Lewis RA, Sobue G, Lawo JP, Mielke O, Durn BL, Cornblath D R, Merkies IS; on behalf of the PATH study group. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (CIDP), a multicenter randomized double-blind placebo-controlled trial: the PATH Study. Lancet Neurology 2018; 17: 35-46.

Schaik van IN, Mielke O; PATH study group. Intravenous versus subcutaneous immunoglobulin - Authors' reply. Lancet Neurology 2018; 17: 393-394.

Schira J, Heinen A, Poschmann G, Ziegler B, Hartung HP, Stühler K, Küry P. Secretome analysis of nerve repair mediating Schwann cells reveals Smad dependent trophism. FASEB Journal 2018, in press.

Schnitzler S, Hartmann CJ, Groiss SJ, Wojtecki L, Schnitzler A, Vesper J, Hirschmann J. Occurrence of thalamic high frequency oscillations in patients with different tremor syndromes. Clinical Neurophysiology 2018; 129: 959-966.

Seitz RJ, Meisel S, Moll M, Wittsack HJ, Junghans U, Siebler M. Impact of the MRI “Perfusion-Diffusion Mismatch” for thrombolysis in stroke. Neurology 2018, in press

Seitz RJ, Paloutzian RF, Angel HF. From Believing to Belief: A General Theoretical Model. Journal of Cognitive Neuroscience 2018; 30: 1254-1264.

Steigerwald F, Timmermann L, Kühn A, Schnitzler A, Reich MM, Kirsch, AD, Barbe MT, Visser-Vandewalle V, Hübl J, Lipp A, Groiss SJ, Moldovan A-S, Lin S, Carcieri S, Manola L, Volkmann J. Pulse duration settings in subthalamic stimulation for Parkinson’s disease. Movement Disorders 2018; 33: 165-169.

Stettner M, Albrecht P, Derksen A, Hartmann C, Turowski B, Neuen-Jacob E, Hartung HP, Kieseier B, Arendt G. Clinical improvement precedes lesion size regression in a severe case of acute disseminated encephalomyelitis. BMJ Case Reports 2018, in press.

Stettner M, Zenker J, Klingler F, Szepanowski F, Hartung HP, Mausberg AK, Kleinschnitz C, Chrast R, Kieseier BC. The Role of Peripheral Myelin Protein 2 in Remyelination. Cellular and Molecular Neurobiology 2018; 38: 487-496.

Stöckel A, Paassen B, Dickfelder R, Göpfert JP, Brazda N, Müller HW, Cimiano P, Hartung M, Klinger R. SCIE: information extraction for spinal cord injury preclinical experiments – a webservice and open source toolkit. bioRxiv 2018, in press.

Szepanowski F, Szepanowski LP, Mausberg AK, Kleinschnitz C, Kieseier BC, Stettner M. Lysophosphatidic acid propagates post-injury Schwann cell dedifferentiation through LPA1 signaling. Neuroscience Letters 2018; 662: 136-141.

Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurology 2018; 17: 162-173.

Torres KJ, Aguirre-Cruz L, Göttle P, Ziegler B, Muñoz Esquivel J, Flores-Rivera J, Reyes-Terán G, Corona T, Küry P. Cultivo de células del sistema nervioso. Cultivo Primario de Oligodendrocitos de Cerebro 2018, in press.

Trenado C, Elben S, Petri D, Hirschmann J, Groiss SJ, Vesper J, Schnitzler A, Wojtecki L. Combined Invasive Subcortical and Non-invasive Surface Neurophysiological Recordings for the Assessment of Cognitive and Emotional Functions in Humans. Journal of Visualized Experiments 2018, in press.

Trenado C, Elben S, Friggemann L, Groiss SJ, Vesper J, Schnitzler A, Wojtecki L. Intraoperative Localization of the Subthalamic Nucleus using Long-Latency Somatosensory Evoked Potentials. Neuromodulation 2018; 21: 582-587.

Trenado C, Boschheidgen M, Rübenach J, N'Diaye K, Schnitzler A, Mallet L, Wojtecki L. Assessment of Metacognition and Reversal Learning in Parkinson's Disease: Preliminary Results. Frontiers in Human Neuroscience 2018; 12: 343.

Urban P, Jacobi C, Jander S. Therapiestandards und individualisierte Therapie bei der Myasthenia gravis. Aktuelle Neurologie 2018, in press.

Vogel F, Hemmer B. Liquorzirkulationsstörungen. In: Klockgether T, Dodel R (eds.) Kurzlehrbuch Neurologie. 2018, in press.

Wattjes MP, Wijburg MT, van Eijk J, Frequin S, Uitdehaag BMJ, Barkhof F, Warnke C, Killestein J; Dutch-Belgian Natalizumab-Associated PML Study Group. Inflammatory natalizumab-associated PML: baseline characteristics, lesion evolution and relation with PML-IRIS. Journal of Neurology, Neurosurgery & Psychiatry 2018: 89: 535-541.

Weismüller B, Ghio M, Logmin K, Hartmann C, Schnitzler A, Pollok B, Südmeyer M, Bellebaum C. Effects of feedback delay on learning from positive and negative feedback in patients with Parkinson's disease off medication. Neuropsychologia. 2018; 117: 46-54.

Wiendl H, Kieseier BC. Fragen und Antworten zur Neuroimmunologie. Verlag Hans Huber, Bern, 2018, in press.

Wijburg MT, Kleerekooper I, Lissenberg-Witte BI, de Vos M, Warnke C, Uitdehaag BM, Barkhof F, Killestein J, Wattjes MJ. Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis. JAMA Neurology 2018; 75: 827-833.

Wijburg MT, Warnke C, Barkhof F, Uitdehaag BMJ, Killestein J, Wattjes MP. Performance of PML diagnostic criteria in natalizumab-associated PML: data from the Dutch-Belgian cohort. Journal of Neurology, Neurosurgery & Psychiatry 2018, in press.

Wittenberg MA, Baumgarten TJ, Schnitzler A, Lange J. U-shaped Relation between Prestimulus Alpha-band and Poststimulus Gamma-band Power in Temporal Tactile Perception in the Human Somatosensory Cortex. Journal of Cognitive Neuroscience 2018; 4: 552-564.

Wojtecki L, Schnitzler A. Movement disorders. In: Azari N, et al. (eds.) Encyclopedia of Sciences and Religions. Thieme, 2018, in press.

Wray S, Havrdova E, Snydman DR, Arnold DL, Cohen JA, Coles AJ, Hartung HP, Selmaj KW, Weiner HL, Daizadeh N, Margolin DH, Chirieac MC, Compston DAS. Infection risk with alemtuzumab decreases over time: pooled analysis of 6-year data from the CAMMS223, CARE-MS I, and CARE-MS II studies and the CAMMS03409 extension study. Multiple Sclerosis 2018, in press.

Zettl UK, Hecker M, Aktas O, Wagner T, Rommer PS. Interferon β-1a and β-1b for patients with multiple sclerosis: updates to current knowledge. Expert Review of Clinical Immunology 2018; 14: 137-153.

Zeus T, Jander S. Akutes Koronarsyndrom und Schlaganfall - interdisziplinäres Management. Aktuelle Kardiologie 2018, in press.

Zöllner HJ, Butz M, Kircheis G, Klinker S, Häussinger D, Schmitt B, Schnitzler A, Wittsack HJ. Ammonia-weighted imaging by chemical exchange saturation transfer MRI at 3 T. NMR in Biomedicine 2018; 31 :e3947.

MediathekInformation und Wissen
LageplanSo finden Sie uns